GB0522045D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB0522045D0
GB0522045D0 GB0522045A GB0522045A GB0522045D0 GB 0522045 D0 GB0522045 D0 GB 0522045D0 GB 0522045 A GB0522045 A GB 0522045A GB 0522045 A GB0522045 A GB 0522045A GB 0522045 D0 GB0522045 D0 GB 0522045D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0522045A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GB0522045A priority Critical patent/GB0522045D0/en
Publication of GB0522045D0 publication Critical patent/GB0522045D0/en
Priority to PCT/EP2006/067773 priority patent/WO2007048811A1/en
Ceased legal-status Critical Current

Links

GB0522045A 2005-10-28 2005-10-28 Pharmaceutical compositions Ceased GB0522045D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0522045A GB0522045D0 (en) 2005-10-28 2005-10-28 Pharmaceutical compositions
PCT/EP2006/067773 WO2007048811A1 (en) 2005-10-28 2006-10-25 Pharmaceutical compositions comprising tricalcium phosphate and calcium carbonate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0522045A GB0522045D0 (en) 2005-10-28 2005-10-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB0522045D0 true GB0522045D0 (en) 2005-12-07

Family

ID=35515941

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0522045A Ceased GB0522045D0 (en) 2005-10-28 2005-10-28 Pharmaceutical compositions

Country Status (2)

Country Link
GB (1) GB0522045D0 (en)
WO (1) WO2007048811A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008001640A1 (en) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Use of hydroxyproline to prepare an alloy composition intended to promote the growth of an animal, such as fish, birds and mammals.
GR1007316B (en) * 2010-05-31 2011-06-14 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Pharmaceutical composition of carbon calcium tablets
AU2012354056B2 (en) 2011-12-13 2017-10-05 Amorphical Ltd. Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
US20150374747A1 (en) * 2013-02-11 2015-12-31 Amorphical Ltd. Amorphous calcium carbonate for accelerated bone growth
EP3174409A4 (en) * 2014-07-31 2018-01-17 Amorphical Ltd. Encapsulated amorphous calcium carbonate compositions
CN107921060A (en) 2015-06-04 2018-04-17 艾玛菲克有限公司 Composition for the amorphous calcium carbonate for sucking administration, sublingual administration or buccal administration
JP7152785B2 (en) 2016-10-25 2022-10-13 アモーフィカル リミテッド． Amorphous Calcium Carbonate for Leukemia Treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
WO1995010290A1 (en) * 1993-10-13 1995-04-20 Warner-Lambert Company Antacid pharmaceutical composition
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6790462B2 (en) * 2001-08-09 2004-09-14 Rhodia Inc. Calcium dietary supplement
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses

Also Published As

Publication number Publication date
WO2007048811A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
HK1244267A1 (en) Pharmaceutical compositions comprising (r)-n-methylnaltrexone
GB0513692D0 (en) Novel pharmaceutical compositions
EP1765283A4 (en) Pharmaceutical compositions
GB0409703D0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
IL188352A0 (en) Pharmaceutical compositions
ZA200708705B (en) Pharmaceutical composition
IL187748A0 (en) Pharmaceutical compositions containing misoprostal
ZA200804103B (en) Pharmaceutical compositions
EP1805154A4 (en) Pharmaceutical compositions
EP1937255A4 (en) Pharmaceutical composition
EP1862184A4 (en) Pharmaceutical composition
GB0522045D0 (en) Pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
EP1845944A4 (en) Pharmaceutical compositions
ZA200803566B (en) Pharmaceutical compositions
GB0514259D0 (en) Pharmaceutical compositions
EP1747205A4 (en) Pharmaceutical compositions
GB0502792D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0411502D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions
GB0515306D0 (en) Pharmaceutical compositions
GB0525269D0 (en) Pharmaceutical compositions
GB0513693D0 (en) Novel pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)